STOCK TITAN

Elutia to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
conferences earnings

Rhea-AI Summary

Elutia Inc. (Nasdaq: ELUT) will report its first quarter 2024 financial results on May 9, 2024. The company specializes in drug-eluting biomatrix products. A conference call and webcast will be held on the same day.

Loading...
Loading translation...
Argus Session date unavailable
+4.64% session move Open Argus
Details

News Market Reaction – ELUT

The recorded move for ELUT in the trading session of this news was +4.64%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

SILVER SPRING, Md., May 02, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a company pioneering drug-eluting biomatrix products, today announced that it will release its first quarter 2024 financial results after market close on Thursday, May 9, 2024. Members of the Company’s management team will host a conference call and webcast starting at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time on the same day.

The conference call can be accessed using the following information:  

Webcast: Click here
U.S. Investors: 877-407-8029
International Investors: 201-689-8029
Conference ID: 13746000

Please log in approximately 10 minutes prior to the scheduled start time. A live and archived webcast of the event will be available on the “Investors” section of the Elutia website at https://investors.elutia.com/.

About Elutia

Elutia develops and commercializes biologic products to improve compatibility between medical devices and the patients who need them. With a growing population in need of implantable technologies, Elutia’s mission is humanizing medicine so patients can thrive without compromise. For more information, visit www.Elutia.com.

Investors:
Matt Steinberg
FINN Partners
matt.steinberg@finnpartners.com


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Elutia report its first quarter 2024 financial results?

Elutia will report its first quarter 2024 financial results on Thursday, May 9, 2024.

What products does Elutia specialize in?

Elutia specializes in drug-eluting biomatrix products.

How can investors access the conference call and webcast?

Investors can access the conference call and webcast on the Elutia website under the 'Investors' section.

Keep reading